MLLr ALL blasts express high levels of BCL-2, BAX, and BIM
MLL/AF4 activates BCL2 through H3K79 methylation
MLLr ALL cells are exquisitely sensitive to BCL-2 antagonist ABT-199
ABT-199 treatment synergizes with H3K79 methylation inhibitors on MLLr samples